- Home
- ROIV vs SKM Comparison
ROIV vs SKM Comparison
Compare ROIV & SKM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- SKM
- Stock Information
- Founded
- ROIV 2014
- SKM 1984
- Country
- ROIV United Kingdom
- SKM South Korea
- Employees
- ROIV N/A
- SKM N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- SKM Telecommunications Equipment
- Sector
- ROIV Health Care
- SKM Telecommunications
- Exchange
- ROIV Nasdaq
- SKM Nasdaq
- Market Cap
- ROIV 7.8B
- SKM 8.6B
- IPO Year
- ROIV N/A
- SKM 1996
- Fundamental
- Price
- ROIV $11.85
- SKM $22.53
- Analyst Decision
- ROIV Buy
- SKM Hold
- Analyst Count
- ROIV 3
- SKM 1
- Target Price
- ROIV $15.25
- SKM N/A
- AVG Volume (30 Days)
- ROIV 4.6M
- SKM 340.4K
- Earning Date
- ROIV 08-11-2025
- SKM 08-06-2025
- Dividend Yield
- ROIV N/A
- SKM 3.77%
- EPS Growth
- ROIV N/A
- SKM N/A
- EPS
- ROIV N/A
- SKM 3.45
- Revenue
- ROIV $23,233,000.00
- SKM $13,204,780,911.00
- Revenue This Year
- ROIV $3.28
- SKM N/A
- Revenue Next Year
- ROIV $156.84
- SKM $2.71
- P/E Ratio
- ROIV N/A
- SKM $11.70
- Revenue Growth
- ROIV N/A
- SKM 0.25
- 52 Week Low
- ROIV $8.73
- SKM $19.84
- 52 Week High
- ROIV $13.06
- SKM $24.58
- Technical
- Relative Strength Index (RSI)
- ROIV 58.16
- SKM 52.96
- Support Level
- ROIV $10.90
- SKM $22.33
- Resistance Level
- ROIV $12.12
- SKM $22.63
- Average True Range (ATR)
- ROIV 0.30
- SKM 0.20
- MACD
- ROIV 0.03
- SKM 0.01
- Stochastic Oscillator
- ROIV 77.87
- SKM 81.82
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About SKM SK Telecom Co. Ltd.
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.6 million pay TV customers (6.8 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.